Currently out of the existing stock ratings of Per Ostlund, 17 are a BUY (94.44%), 1 are a HOLD (5.56%).

Per Ostlund

Work Performance Price Targets & Ratings Chart

Analyst Per Ostlund, currently employed at CRAIG HALLUM, carries an average stock price target met ratio of 66.67% that have a potential upside of 45.61% achieved within 181 days.

Per Ostlund’s has documented 29 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ICAD, icad inc at 16-May-2023.

Wall Street Analyst Per Ostlund

Analyst best performing recommendations are on ICAD (ICAD INC).
The best stock recommendation documented was for ICAD (ICAD INC) at 5/16/2023. The price target of $2.5 was fulfilled within 63 days with a profit of $1.36 (119.3%) receiving and performance score of 18.94.

Average potential price target upside

CEMI Chembio Diagnostics CDNA Caredx EXAS EXACT Sciences ICAD icad inc

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

3 years 3 months 30 days ago
(22-Jul-2021)

1/1 (100%)

$6.31 (110.90%)

484

Buy

$10

$9.54 (2073.91%)

$8

3 years 11 months 18 days ago
(03-Dec-2020)

0/3 (0%)

$4.16 (59.27%)

Buy

4 years 5 months 4 days ago
(17-Jun-2020)

2/2 (100%)

$1.27 (34.05%)

165

Buy

$12

$11.54 (2508.70%)

$9

4 years 7 months 5 days ago
(16-Apr-2020)

4/4 (100%)

$2.83 (60.84%)

188

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Per Ostlund?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?